|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,125.04 |
3.24% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$64,225.50 |
3.01% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$53,506.62 |
2.51% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$49,835.57 |
2.34% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$48,028.52 |
2.25% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,456.20 |
2.22% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,377.20 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,456.41 |
2.18% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$46,000.98 |
2.16% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$45,557.08 |
2.14% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$45,701.65 |
2.14% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,244.28 |
2.12% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,887.52 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,571.25 |
2.09% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,494.32 |
2.09% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,157.33 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,860.66 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,530.52 |
2.04% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$42,570.46 |
2.00% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$42,594.96 |
2.00% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$42,483.08 |
1.99% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,368.48 |
1.99% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$42,132.15 |
1.98% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,298.43 |
1.98% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$42,005.85 |
1.97% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$42,073.11 |
1.97% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,507.44 |
1.95% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$41,226.61 |
1.93% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$40,763.36 |
1.91% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$40,720.09 |
1.91% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$40,247.00 |
1.89% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$40,079.88 |
1.88% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,678.18 |
1.86% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$39,691.88 |
1.86% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$39,344.69 |
1.84% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,103.68 |
1.83% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$38,670.23 |
1.81% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,466.58 |
1.80% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,088.30 |
1.79% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,172.84 |
1.79% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,688.73 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,712.85 |
1.77% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,649.08 |
1.76% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$37,524.81 |
1.76% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,935.13 |
1.73% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,976.17 |
1.73% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$36,850.54 |
1.73% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,610.49 |
1.72% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$33,687.18 |
1.58% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,371.40 |
1.42% |
| US Dollar |
$USD |
|
1,685 |
$1,685.06 |
0.08% |
| Danish Krone |
$DKK |
|
5,979 |
$931.97 |
0.04% |
| New Zealand Dollar |
$NZD |
|
430 |
$248.33 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|